ABBV - AbbVie Inc.
Close
192.87
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:01:36 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.46%
PREVIOUS CLOSE
CHG
CHG%
$192.87
-20.90
0.12%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-04 | 2022-11-04 | 2023-02-17 | 2023-05-05 | 2023-08-07 | 2023-11-06 | 2024-02-20 | 2024-05-03 | |
Cash flow financing | -2.679 B | -5.518 B | -9.634 B | -6.192 B | -3.920 B | -2.661 B | -4.449 B | 10.819 B | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | 5.005 B | 7.602 B | 7.428 B | 4.193 B | 6.319 B | 7.574 B | 4.753 B | 4.040 B | |
Net income | 913.000 M | 3.931 B | 2.470 B | 228.000 M | 2.013 B | 1.767 B | 812.000 M | 1.359 B | |
Depreciation | 2.321 B | 2.245 B | 2.400 B | 2.277 B | 2.540 B | 2.301 B | 2.076 B | 2.074 B | |
Changes in inventories | 3.396 B | 3.172 B | 3.579 B | 3.833 B | 4.055 B | 3.981 B | 4.099 B | 4.245 B | |
Changes in receivables | 11.237 B | 10.743 B | 11.254 B | 11.473 B | 11.491 B | 11.412 B | 11.155 B | 11.949 B | |
Investing Cashflow | 130.000 M | 1.286 B | -448.000 M | -499.000 M | -341.000 M | -369.000 M | -800.000 M | -9.588 B | |
Net Borrowings | 58.465 B | 53.157 B | 49.641 B | 50.911 B | 47.709 B | 42.915 B | 41.637 B | 51.324 B | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -143.000 M | -177.000 M | -213.000 M | -175.000 M | -178.000 M | -219.000 M | -205.000 M | -193.000 M | |
Cash Change | 9.961 B | 11.879 B | 9.229 B | 6.722 B | 8.766 B | 13.290 B | 12.816 B | 18.069 B |